97 related articles for article (PubMed ID: 22087438)
1. Reduced grey matter metabolism due to white matter edema allows optimal assessment of brain tumors on 18F-FDG-PET.
Pourdehnad M; Basu S; Duarte P; Okpaku AS; Saboury B; Hustinx R; Alavi A
Hell J Nucl Med; 2011; 14(3):219-23. PubMed ID: 22087438
[TBL] [Abstract][Full Text] [Related]
2. Partial volume correction and image segmentation for accurate measurement of standardized uptake value of grey matter in the brain.
Bural G; Torigian D; Basu S; Houseni M; Zhuge Y; Rubello D; Udupa J; Alavi A
Nucl Med Commun; 2015 Dec; 36(12):1249-52. PubMed ID: 26426967
[TBL] [Abstract][Full Text] [Related]
3. The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas.
Gross MW; Weber WA; Feldmann HJ; Bartenstein P; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):989-95. PubMed ID: 9719107
[TBL] [Abstract][Full Text] [Related]
4. Utility of gray-matter segmentation of ictal-Interictal perfusion SPECT and interictal
Elkins KC; Moncayo VM; Kim H; Olson LD
Epilepsy Res; 2017 Feb; 130():93-100. PubMed ID: 28171851
[TBL] [Abstract][Full Text] [Related]
5. Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium.
Zukotynski KA; Fahey FH; Vajapeyam S; Ng SS; Kocak M; Gururangan S; Kun LE; Poussaint TY
J Nucl Med; 2013 Aug; 54(8):1237-43. PubMed ID: 23801675
[TBL] [Abstract][Full Text] [Related]
6. Combined
Aparicio J; Carreño M; Bargalló N; Setoain X; Rubí S; Rumià J; Falcón C; Calvo A; Martí-Fuster B; Padilla N; Boget T; Pintor L; Donaire A
Neuroimage Clin; 2016; 12():976-989. PubMed ID: 27995064
[TBL] [Abstract][Full Text] [Related]
7. Can the standardized uptake value characterize primary brain tumors on FDG-PET?
Hustinx R; Smith RJ; Benard F; Bhatnagar A; Alavi A
Eur J Nucl Med; 1999 Nov; 26(11):1501-9. PubMed ID: 10552096
[TBL] [Abstract][Full Text] [Related]
8. White matter abnormalities revealed by DTI correlate with interictal grey matter FDG-PET metabolism in focal childhood epilepsies.
Lippé S; Poupon C; Cachia A; Archambaud F; Rodrigo S; Dorfmuller G; Chiron C; Hertz-Pannier L
Epileptic Disord; 2012 Dec; 14(4):404-13. PubMed ID: 23248049
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
[TBL] [Abstract][Full Text] [Related]
10. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.
Prieto E; Martí-Climent JM; Domínguez-Prado I; Garrastachu P; Díez-Valle R; Tejada S; Aristu JJ; Peñuelas I; Arbizu J
J Nucl Med; 2011 Jun; 52(6):865-72. PubMed ID: 21571807
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
Spence AM; Muzi M; Mankoff DA; O'Sullivan SF; Link JM; Lewellen TK; Lewellen B; Pham P; Minoshima S; Swanson K; Krohn KA
J Nucl Med; 2004 Oct; 45(10):1653-9. PubMed ID: 15471829
[TBL] [Abstract][Full Text] [Related]
12. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Pauleit D; Stoffels G; Bachofner A; Floeth FW; Sabel M; Herzog H; Tellmann L; Jansen P; Reifenberger G; Hamacher K; Coenen HH; Langen KJ
Nucl Med Biol; 2009 Oct; 36(7):779-87. PubMed ID: 19720290
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET findings in the Wernicke-Korsakoff syndrome.
Reed LJ; Lasserson D; Marsden P; Stanhope N; Stevens T; Bello F; Kingsley D; Colchester A; Kopelman MD
Cortex; 2003; 39(4-5):1027-45. PubMed ID: 14584565
[TBL] [Abstract][Full Text] [Related]
14. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Lipszyc M; Salmon I; Brotchi J; Levivier M
J Neurosurg; 2004 Sep; 101(3):476-83. PubMed ID: 15352606
[TBL] [Abstract][Full Text] [Related]
15. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Zhu L; Li N; Kung HF; Yang Z
Clin Nucl Med; 2018 Nov; 43(11):e392-e399. PubMed ID: 30179907
[TBL] [Abstract][Full Text] [Related]
16. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Correlation of Histopathology and MRI in Prion Disease.
Mente KP; O'Donnell JK; Jones SE; Cohen ML; Thompson NR; Bizzi A; Gambetti P; Safar JG; Appleby BS
Alzheimer Dis Assoc Disord; 2017; 31(1):1-7. PubMed ID: 28121634
[TBL] [Abstract][Full Text] [Related]
19. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
[TBL] [Abstract][Full Text] [Related]
20. Grey-Matter Metabolism in Relation with White-Matter Lesions in Older Hypertensive Patients with Subjective Memory Complaints: A Pilot Voxel-Based Analysis Study.
Verger A; Hossu G; Kearney-Schwartz A; Bracard S; Roch V; Van der Gucht A; Fay R; Benetos A; Marie PY; Joly L
Cerebrovasc Dis; 2016; 42(1-2):106-9. PubMed ID: 27071040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
